Literature DB >> 8359900

Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

L de Repentigny1, S Petitbois, M Boushira, E Michaliszyn, S Sénéchal, N Gendron, S Montplaisir.   

Abstract

A number of studies have substantiated the pivotal role of innate defense mechanisms in protection against invasive aspergillosis. However, experiments demonstrating increased resistance to lethal intravenous (i.v.) infection with Aspergillus fumigatus conidia in cortisone-treated or untreated mice preinfected with a sublethal dose of conidia and protection of turkeys inoculated subcutaneously with a killed A. fumigatus germling vaccine against subsequent aerosol challenge led us to speculate that acquired immunity may also contribute to host defense against Aspergillus infection. Five-week-old male BALB/c mice were inoculated i.v. with 1.0 x 10(4) viable conidia or saline and challenged i.v. with 1.0 x 10(6) conidia after 7, 15, or 21 days. No protection against challenge was found after 7 days. However, significant and reproducible protection was observed after 15 and 21 days. Mortality was reduced from 90% in control mice to 53% in preinfected mice 40 days after challenge (P = 0.0002). Increased survival was correlated with decreased content of chitin in lungs, liver, and kidneys 4 and 7 days after challenge (P < 0.05). Mice were again inoculated with 1.0 x 10(4) conidia or saline, and after 21 days, 1.0 x 10(8) or 2.0 x 10(8) splenocytes were transferred to naive syngeneic recipients; 2.0 x 10(8) immune splenocytes conferred significant protection (P = 0.0001) against i.v. challenge with 1.0 x 10(6) conidia, and mortality decreased from 83 to 48% 40 days after challenge. Transfer of immune serum offered no protection despite the presence of antibody against a hyphal homogenate of A. fumigatus, which was absent in the sera of control mice. Protection by immune splenocytes was maintained after selective depletion of T cells but was abolished after removal of plastic-adherent splenocytes. Adherent cells were characterized as macrophages by using morphological criteria, nonspecific esterase, and MAC-1 monoclonal antibody. Production of hydrogen peroxide by peritoneal and splenic macrophages from preinfected mice was the same as and lower than, respectively, that from uninfected controls. However, phagocytosis of conidia by peritoneal or splenic macrophages from mice preinfected i.v. or intratracheally was significantly increased after 2 and 3 h of coculture compared with that from uninfected animals, whereas in vitro killing of conidia by splenic macrophages was unaltered. Peritoneal or splenic macrophages from control or preinfected mice failed to kill hyphae in vitro. Killing of hyphae by polymorphonuclear leukocytes was not significantly different between mice preinfected i.v. and uninfected controls. Taken together, the results indicate that acquired immunity mediated by activated macrophages can be demonstrated in experimental murine aspergillosis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359900      PMCID: PMC281079          DOI: 10.1128/iai.61.9.3791-3802.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.

Authors:  A Schaffner; C E Davis; T Schaffner; M Markert; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus.

Authors:  M J Corbel; S M Eades
Journal:  Mycopathologia       Date:  1977-02-18       Impact factor: 2.574

3.  Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice.

Authors:  P F Lehmann; L O White
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages.

Authors:  J R Catterall; C M Black; J P Leventhal; N W Rizk; J S Wachtel; J S Remington
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Skin reaction and macrophage migration inhibition tests for polysaccharides from Aspergillus fumigatus and Candida albicans.

Authors:  M Suzuki; Y Hayashi
Journal:  Jpn J Microbiol       Date:  1975-10

6.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT.

Authors:  S M Levitz; R D Diamond
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

9.  Experimental study of the pathogenicity of aspergilli for mice.

Authors:  S Ford; L Friedman
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

10.  Experimental aspergillosis in mice: aspects of resistance.

Authors:  G R Smith
Journal:  J Hyg (Lond)       Date:  1972-12
View more
  15 in total

1.  Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.

Authors:  K A Marr; M Koudadoust; M Black; S A Balajee
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

Authors:  K V Clemons; G Grunig; R A Sobel; L F Mirels; D M Rennick; D A Stevens
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 4.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

5.  Fungal antigens expressed during invasive aspergillosis.

Authors:  Nicole Denikus; Foteini Orfaniotou; Gerald Wulf; Paul F Lehmann; Michel Monod; Utz Reichard
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.

Authors:  T Madan; P Eggleton; U Kishore; P Strong; S S Aggrawal; P U Sarma; K B Reid
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 7.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

8.  Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells.

Authors:  L de Repentigny; F Aumont; K Bernard; P Belhumeur
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Th1 and Th2 cytokines in mice with invasive aspergillosis.

Authors:  E Cenci; S Perito; K H Enssle; P Mosci; J P Latgé; L Romani; F Bistoni
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

10.  Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages.

Authors:  E Michaliszyn; S Sénéchal; P Martel; L de Repentigny
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.